Evofem Biosciences

(OTC) EVFM

Current Price$0.01

Market Cap$1.06M

Since IPO (2018)-100%

5 Year-100%

1 Year-20%

1 Month+23%

Evofem Biosciences Financials at a Glance

Market Cap

$1.06M

Revenue (TTM)

$20.24M

Net Income (TTM)

-$6.05M

EPS (TTM)

-$0.05

P/E Ratio

-0.16

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Price

$0.01

Volume

614,709

Open

$0.01

Price

$0.01

Volume

614,709

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.02

Estimated Earnings Date

Aug 19, 2026

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Price

$0.01

Volume

614,709

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.02

Estimated Earnings Date

Aug 19, 2026

EVFM News

Evofem Revenue Jumps 16 Percent in Q2

Motley Fool Markets TeamAug 14, 2025

Why Evofem Biosciences Stock Is Falling Today

Prosper Junior BakinyMar 5, 2021

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Evofem Biosciences

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Saundra L. Pelletier

Website

www.evofem.com

Headquarters

San Diego, CA 92130, US

EVFM Financials

Key Financial Metrics (TTM)

Gross Margin

74.13%

Operating Margin

-17.08%

Net Income Margin

-29.90%

Return on Equity

8.58%

Return on Capital

N/A

Return on Assets

-81.30%

Earnings Yield

-6.25%

Dividend Yield

0.00%

Payout Ratio

-2.21%

Stock Overview

Market Cap

$1.06M

Shares Outstanding

132.53M

Volume

614.71K

Avg. Volume

291.50K

Financials (TTM)

Gross Profit

$15.00M

Operating Income

-$3.46M

EBITDA

-$2.95M

Operating Cash Flow

-$251.00K

Capital Expenditure

-$7.00K

Free Cash Flow

-$258.00K

Cash & ST Invst.

$2.38M

Total Debt

$52.46M

Evofem Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$899.00K

+6.4%

Gross Profit

$414.00K

-13.8%

Gross Margin

46.05%

N/A

Market Cap

$1.06M

N/A

Market Cap/Employee

$33.13K

N/A

Employees

N/A

Net Income

-$5.49M

-673.7%

EBITDA

-$4.46M

-901.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$2.38M

+976.5%

Total Debt

$52.46M

+14.7%

Accounts Receivable

$560.00K

-51.3%

Inventory

$1.89M

-16.5%

Long Term Debt

$27.00K

+440.0%

Short Term Debt

$52.43M

+14.7%

Return on Assets

-81.30%

N/A

Return on Invested Capital

4.85%

N/A

Free Cash Flow

$2.30M

+310.5%

Operating Cash Flow

$2.30M

+310.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ISCOInternational Stem Cell Corporation

ISCOInternational Stem Cell Corporation$0.20+11.11%

BPTHBio-Path Holdings, Inc.

BPTHBio-Path Holdings, Inc.$0.05+42.86%

MRZMMarizyme, Inc.

MRZMMarizyme, Inc.$0.00+0.00%

CAIHFChia Tai Enterprises International Limited

CAIHFChia Tai Enterprises International Limited$0.28+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92-0.01%

TAT&T

TAT&T$20.58+0.00%

INTCIntel

INTCIntel$120.35-0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.30-0.15%

CLROClearOne

CLROClearOne$6.48+1.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

ONDSOndas

ONDSOndas$7.41-0.06%

Questions About EVFM

What is the current price of Evofem Biosciences?

Evofem Biosciences is trading at $0.01 per share.

What is the 52-week range for Evofem Biosciences?

Over the past 52 weeks, Evofem Biosciences has traded between $0.00 and $0.02.

How much debt does Evofem Biosciences have?

As of the most recent reporting period, Evofem Biosciences reported total debt of $52.46M.

How much cash does Evofem Biosciences have on hand?

Evofem Biosciences reported $2.38M in cash and cash equivalents in its most recent financial results.

What is Evofem Biosciences’s dividend yield?

Evofem Biosciences does not currently have a dividend yield.

Evofem Biosciences

Evofem Biosciences Financials at a Glance

EVFM News

Evofem Revenue Jumps 16 Percent in Q2

Why Evofem Biosciences Stock Is Falling Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Evofem Biosciences

EVFM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Evofem Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About EVFM

What is the current price of Evofem Biosciences?

What is the 52-week range for Evofem Biosciences?

How much debt does Evofem Biosciences have?

How much cash does Evofem Biosciences have on hand?

What is Evofem Biosciences’s dividend yield?

Premium Investing Services